AeroLeads people directory · profile
Greg Kunst Email & Phone Number
Chief Executive Officer and Board Member
at
Valitor
1 work email found
@valitorbio.com
LinkedIn matched
✓ Verified May 2026
4 data sources
Profile completeness 86%
Current company
Role
Chief Executive Officer and Board Member
Location
Greater Seattle Area, United States, United States
Company size
Who is Greg Kunst? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Greg Kunst is listed as Chief Executive Officer and Board Member at Valitor, a company with 20 employees, based in Greater Seattle Area, United States, United States. AeroLeads shows a work email signal at valitorbio.com and a matched LinkedIn profile for Greg Kunst.
Greg Kunst previously worked as Founder, Chief Executive Officer, and Board Director at Aurion Biotech and Board Director at Pr3Vent Inc. Greg Kunst holds B.S., Economics from Brigham Young University.
Company email context
Email format at Valitor
This section adds company-level context without repeating Greg Kunst's masked contact details.
{first_initial}{last}@valitorbio.com
89% confidence
AeroLeads found 1 current-domain work email signal for Greg Kunst. Compare company email patterns before reaching out.
Profile bio
About Greg Kunst
I am a Chief Executive Officer and Board Director accelerating global business growth and market expansion for biotech, pharmaceutical, and medical technology industries. My experience includes strategically planning, developing, and launching new products that have successfully expanded access to new and existing markets.In addition to my work in organizational and product development, I am accustomed to serving as a Board Director and Strategic Advisor to multiple organizations. As Board Director at Pr3vent, I’m transforming the industry landscape through my expertise in product management and strategic planning to deliver innovative healthcare solutions.EXPERTISE:➥ Strength in leading all functional areas of an organization while building partnerships, pushing expansion opportunities, and maintaining a forward-focused growth pattern.➥ Extensive experience steering new drug development and commercialization initiatives through pre-clinical, clinical, regulatory, and manufacturing strategies.➥ Proven history raising $300M+ in capital through equity and debt based on a deep relationship with big pharma strategics, M&A practices, and partnering opportunities.➥ A capacity to connect and lead roundtable discussions with C-level and Board leaders and develop new medical treatments, devises, and drugs for global market distribution.➥ Talent for developing numerous new therapeutic areas that shaped how medicine is practices including negative-pressure would therapy, micro-invasive glaucoma surgery, retina pharmaceuticals, and cell therapies.AWARDS:★ 2024 Ernst & Young Entrepreneur of the Year★ 2023 Puget Sound Business Journal Healthcare Leader of the Year★ 2022 Galien Foundation Prix Galien Award☛ Key Skills ☚ ✦ Strategy, Execution, & Leadership✦ Global Business Development✦ Continuous Improvement✦ Organizational Development✦ Product & Program Management✦ C-Level Thought Leadership✦ Fundraising & Investor Strategy✦ Policy & Process Development✦ Board Leadership & Public Speaking✦ Cross-Functional Collaboration✦ Team Leadership & Coaching✦ Medical & Government Affairs✦ Risk & Compliance Control✦ Stakeholder Engagement✦ Marketing & Brand Strategy✦ Change Management
Current workplace
Greg Kunst's current company
Company context helps verify the profile and gives searchers a useful next step.
Valitor
12 roles
Greg Kunst work experience
A career timeline built from the work history available for this profile.
Founder, Chief Executive Officer, And Board Director
CurrentFounded new venture-backed startup from scratch to develop clinical-state cell therapy assets for eye diseases. Grew company from 1 to 90 employees and secured $132M+ in series-C venture backing from top-tier investors including Deerfield, KKR, Petrichor, and Alcon and +$200M in total venture financing. Oversaw development pipeline from pre-clinical.
Apr 2021 - Present
Board Director
CurrentCurrently serving as an independent Board Member for series A, venture-backed startup as well as a member of compensation and audit committees.
Apr 2023 - Present
Strategic Advisor
Current
Jun 2019 - Present
Vice President Global Marketing And Market Access
Built and led commercial franchise team in strategizing and launching long-term product pipeline for $350M ophthalmic medical technology and pharmaceutical company. Led team of 40+ employees to propel key business initiatives in global marketing, business development, and medical affairs to strengthen company posture and visibility. Unlocked new market.
Oct 2018 - Mar 2021
Senior Director, Global Market Access And Business Development
Managed key growth initiatives in global market reimbursement, international commercialization planning, and health technology assessments with global impact. Authored and executed targeted development and commercial plans based on global market trends including micro-invasive glaucoma surgery implants and drug delivery systems. Extended category 3 CPT.
Apr 2015 - Oct 2018
Global Marketing Director - Retina Pharmaceuticals
Reinforced global launch, commercial, medical affairs, capabilities development, and market access infrastructure for first biologic / specialty pharmaceutical treatment for $12B ophthalmic pharmaceutical, medical device, and product global leader. Directed global marketing teams in executive rigorous commercial and market preparedness strategies for.
Jul 2013 - Mar 2015
Global Marketing Director - Surgical Glaucoma
Guided all development in global marketing, promotional, campaign, portfolio, product, M&A, and phase IV clinical trial strategies for new business unit. Launched new unit into 85+ global affiliates within 9 months including global infrastructure to ensure longevity and growth.➥ Seamlessly led integration of new business unit with global commercial.
Mar 2010 - Jul 2013
Director, Health Economics, Reimbursement, & Market Access - Asia Pacific And Latin America Regions
Played an integral role commercializing flagship VAC therapy product line in Japan for $2.1B global leader in advanced wound care, regenerative medicine, and therapeutic surface products. Sat at the roundtable of the Asia Pacific (APAC) and Latin America executive teams tasked with driving market entry in new and competitive markets.➥ Negotiated with.
Aug 2009 - Mar 2010
Director, Global Reimbursement And Market Access
Built first global reimbursement team to handle product reimbursement efforts for new and existing products including OUS government payors, U.S. private payors, Medicare, and state Medicaid. Lobbied congressional staff and federal agencies to change existing HCPCS coding for negative pressure wound therapy products.➥ Created clinical trials and.
Feb 2008 - Aug 2009
Global Health Economics Manager
Built new health economics and outcomes function for Europe, Canada, and the U.S. while developing global value dossiers for new and existing products. Designed studies to demonstrate positive clinical and cost impact of VAC therapy system that led to widespread buy in. Developed budget impact product models highlighting economic value to customers.
May 2006 - Feb 2008
Project Manager
Jan 2003 - Oct 2004
5 education records
Greg Kunst education
B.S., Economics
Mba, General Management And Strategy
Novartis Advance Program, Strategy And Communications
M2 Leadership Program - The Role Of The Leader
Novartis
Master Of Business Administration - Mba
FAQ
Frequently asked questions about Greg Kunst
Quick answers generated from the profile data available on this page.
What company does Greg Kunst work for?
Greg Kunst works for Valitor.
What is Greg Kunst's role at Valitor?
Greg Kunst is listed as Chief Executive Officer and Board Member at Valitor.
What is Greg Kunst's email address?
AeroLeads has found 1 work email signal at @valitorbio.com for Greg Kunst at Valitor.
Where is Greg Kunst based?
Greg Kunst is based in Greater Seattle Area, United States, United States while working with Valitor.
What companies has Greg Kunst worked for?
Greg Kunst has worked for Valitor, Aurion Biotech, Pr3Vent Inc, Oculogica, and Glaukos Corporation.
Who are Greg Kunst's colleagues at Valitor?
Greg Kunst's colleagues at Valitor include Livia Wilz Brier.
How can I contact Greg Kunst?
You can use AeroLeads to view verified contact signals for Greg Kunst at Valitor, including work email, phone, and LinkedIn data when available.
What schools did Greg Kunst attend?
Greg Kunst holds B.S., Economics from Brigham Young University.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial